What TV doesn't, print can't; we deliver.
What TV doesn't, print can't; we deliver.
NEW DELHI: Coal India has started its third phase of the Thalassaemia Bal Sewa Yojna, a Corporate Social Responsibility (CSR) project. Started in 2017, the project aims to provide financial help to improve the lives of children suffering from severe blood disorders through life-saving stem cell transplantation.
The plan is to benefit children suffering from thalassaemia and aplastic anaemia throughout India, giving them hope for a healthy, transfusion-free future.
The first event took place at Sir Ganga Ram facility in Delhi, with the signing of MoU. The effort is expected to benefit hundreds of children who visit the hospital for treatment. In addition, coal India signed MoUs with 17 more hospitals across India.
Thalassaemia major, a genetic blood condition, necessitates ongoing blood transfusions unless a successful stem cell transplant is performed. Aplastic anaemia, which occurs when the bone marrow fails to create enough blood cells, can result in serious complications.
The Thalassaemia Bal Sewa Yojna aims to plug the financial gap that has previously prevented many children from receiving these important transplants, particularly those with fully matched sibling or unrelated donors.
Coal India Director Vinay Ranjan shared that this scheme is part of a larger effort, with Sir Ganga Ram Hospital becoming the 15th hospital to sign the MoU since the project’s inception in 2017. With a three-phase budget of ₹70 crore, the initiative may expand to ₹100 crore if needed, with a vision to screen and rehabilitate cured children.
He told The New Indian, “Other than these collaborations with hospitals, we also conduct screening camps in various cities to identify this disorder and raise awareness. Right now, we need to broaden this screening program, especially in states with a high concentration of thalassemia cases.”
Dr. DS Rana, Chairman Sir Ganga Ram Trust and Dr. Ajay Swaroop, Chairman Sir Ganga Ram Hospital, expressed their gratitude towards Coal India for spearheading this life-changing project.
Dr. Anupam Sachdeva, Head of Pediatric Hematology and Stem Cell Transplant Services, lauded the initiative, emphasising its potential to transform lives by eliminating the financial barriers to treatment.
Shobha Tuli, Secretary of Thalassemics India, spoke on the importance of raising awareness about the availability of such funding and support within the community. She urged families affected by these conditions to seek information and assistance at the right time to access the help they need.
The event concluded with the distribution of thalassemia treatment kits to affected children, symbolising a new chapter of hope for families battling these diseases.
